Edition:
United States

Health News

AbbVie rheumatoid arthritis drug succeeds in late stage trial

AbbVie Inc on Tuesday said its experimental rheumatoid arthritis (RA) treatment showed significant improvement in physical function, pain and quality of life compared with the commonly prescribed generic drug methotrexate in a late stage clinical trial.

Study shows downside of medical crowdfunding

(Reuters Health) - While crowdfunding platforms can fill insurance gaps, helping patients pay for essential care and avoid medical debt, they are also being used to raise large sums of money for ineffective and experimental treatments, a new study suggests.

Health Reform Watch